Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

S. Korea’s Disgraced Stem Cell Scientist Denied Return To Research

This article was originally published in PharmAsia News

Executive Summary

South Korea again has denied disgraced stem cell-cloning scientist Hwang Woo-suk authorization to return to his research. Hwang was banned by the government two years ago after it was revealed he had falsified groundbreaking research that had gained the world's attention. Hwang has been on trial since 2006, charged with fraud and violations of South Korean laws covering bioethics. In addition to the government action, Seoul National University where he conducted his research also dismissed him. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069440

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel